Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2013-03-14
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Simnad, Virginia, M.D.
- Target Recruit Count
- 36
- Registration Number
- NCT01811290
- Locations
- 🇺🇸
MS Center at Evergreen Health, Kirkland, Washington, United States
News
No news found